Clinical Trial Update: A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation [Phase 1]

View source ↗

Summary

A Phase I study of HY-2003 for moderate to severe submental fullness is currently recruiting, per ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fullness

Drugs mentioned

• HY-2003

Snippet

Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd | Conditions: Moderate or Severe Submental Fullness | Phase 1 | Status: RECRUITING